Novo Nordisk: Why Wegovy Growth Beats Wall Street Expectations
Source: SeekingAlpha
2026-02-23 08:30:00 ET
In my last article, "Novo Nordisk: Will Wegovy And Pipeline Spark Rally?" , I mostly discussed Novo Nordisk's (NONOF) ( NVO ) Q3 results and the efficacy of 20 mg amycretin and UBT251....
Read the full article on Seeking Alpha
For further details see:
Novo Nordisk: Why Wegovy Growth Beats Wall Street Expectations
Madrigal Pharmaceuticals Inc.
NASDAQ: MDGL
MDGL Trading
0.75% G/L:
$427.295 Last:
102,462 Volume:
$429.42 Open:
MDGL Latest News
February 24, 2026 08:00:00 am
Madrigal Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference
February 19, 2026 07:00:00 am
Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Financial Results
MDGL Stock Data
$10,921,013,421
11,446,556
2.73%
146
N/A
Biotechnology & Life Sciences
Healthcare
US
West Conshohocken
